De Visschere PJL - Search Results

1

Splenic ¹⁸F-FDG uptake on baseline PET/CT is associated with oncological outcomes and tumor immune state in uterine cervical cancer.

De Jaeghere EA, Laloo F, Lippens L, Van Bockstal M, De Man K, Naert E, Van Dorpe J, Van de Vijver K, Tummers P, Makar A, De Visschere PJL, De Wever O, Amant F, Denys HG, Vandecasteele K. De Jaeghere EA, et al. Among authors: de visschere pjl. Gynecol Oncol. 2020 Nov;159(2):335-343. doi: 10.1016/j.ygyno.2020.08.001. Epub 2020 Aug 25. Gynecol Oncol. 2020. PMID: 32859399

2

Controversies in MR targeted biopsy: alone or combined, cognitive versus software-based fusion, transrectal versus transperineal approach?

Marra G, Ploussard G, Futterer J, Valerio M; EAU-YAU Prostate Cancer Working Party. Marra G, et al. World J Urol. 2019 Feb;37(2):277-287. doi: 10.1007/s00345-018-02622-5. Epub 2019 Jan 4. World J Urol. 2019. PMID: 30610359 Review.

3

Global Variation in Magnetic Resonance Imaging Quality of the Prostate.

Giganti F, Ng A, Asif A, Chan VW, Rossiter M, Nathan A, Khetrapal P, Dickinson L, Punwani S, Brew-Graves C, Freeman A, Emberton M, Moore CM, Allen C, Kasivisvanathan V; PRIME Quality Improvement Group. Giganti F, et al. Radiology. 2023 Oct;309(1):e231130. doi: 10.1148/radiol.231130. Radiology. 2023. PMID: 37815448 Free article. Clinical Trial.

4

Completion surgery after intensity-modulated arc therapy in the treatment of locally advanced cervical cancer: feasibility, surgical outcome, and oncologic results.

Tummers P, Makar A, Vandecasteele K, De Meerleer G, Denys H, De Visschere P, Delrue L, Villeirs G, Lambein K, den Broecke RV. Tummers P, et al. Int J Gynecol Cancer. 2013 Jun;23(5):877-83. doi: 10.1097/IGC.0b013e31828d1ec0. Int J Gynecol Cancer. 2013. PMID: 23698797

5

Metastatic burden in newly diagnosed hormone-naive metastatic prostate cancer: Comparing definitions of CHAARTED and LATITUDE trial.

Buelens S, Poelaert F, Dhondt B, Fonteyne V, De Visschere P, Ost P, Verbeke S, Villeirs G, De Man K, Rottey S, Decaestecker K, Lumen N. Buelens S, et al. Urol Oncol. 2018 Apr;36(4):158.e13-158.e20. doi: 10.1016/j.urolonc.2017.12.009. Epub 2018 Jan 12. Urol Oncol. 2018. PMID: 29336978 Clinical Trial.

6

EXclusion of non-Involved uterus from the Target Volume (EXIT-trial): an individualized treatment for locally advanced cervical cancer using modern radiotherapy and imaging techniques.

Vandecasteele K, Tummers P, Van Bockstal M, De Visschere P, Vercauteren T, De Gersem W, Denys H, Naert E, Makar A, De Neve W. Vandecasteele K, et al. BMC Cancer. 2018 Sep 17;18(1):898. doi: 10.1186/s12885-018-4800-0. BMC Cancer. 2018. PMID: 30223802 Free PMC article. Clinical Trial.

7

Neo-adjuvant treatment of adenocarcinoma and squamous cell carcinoma of the cervix results in significantly different pathological complete response rates.

Couvreur K, Naert E, De Jaeghere E, Tummers P, Makar A, De Visschere P, Van Bockstal M, Van Dorpe J, De Neve W, Denys H, Vandecasteele K. Couvreur K, et al. BMC Cancer. 2018 Nov 12;18(1):1101. doi: 10.1186/s12885-018-5007-0. BMC Cancer. 2018. PMID: 30419851 Free PMC article.

8

Nodal Oligorecurrent Prostate Cancer: Anatomic Pattern of Possible Treatment Failure in Relation to Elective Surgical and Radiotherapy Treatment Templates.

De Bruycker A, De Bleser E, Decaestecker K, Fonteyne V, Lumen N, De Visschere P, De Man K, Delrue L, Lambert B, Ost P. De Bruycker A, et al. Eur Urol. 2019 May;75(5):826-833. doi: 10.1016/j.eururo.2018.10.044. Epub 2018 Nov 29. Eur Urol. 2019. PMID: 30503072

9

Randomized Phase 1 Trial of Pembrolizumab with Sequential Versus Concomitant Stereotactic Body Radiotherapy in Metastatic Urothelial Carcinoma.

Sundahl N, Vandekerkhove G, Decaestecker K, Meireson A, De Visschere P, Fonteyne V, De Maeseneer D, Reynders D, Goetghebeur E, Van Dorpe J, Verbeke S, Annala M, Brochez L, Van der Eecken K, Wyatt AW, Rottey S, Ost P. Sundahl N, et al. Eur Urol. 2019 May;75(5):707-711. doi: 10.1016/j.eururo.2019.01.009. Epub 2019 Jan 19. Eur Urol. 2019. PMID: 30665814 Clinical Trial.

10

Feasibility study on pre or postoperative accelerated radiotherapy (POP-ART) in breast cancer patients.

Van Hulle H, Vakaet V, Post G, Van Greveling A, Monten C, Hendrix A, Van de Vijver K, Van Dorpe J, De Visschere P, Braems G, Vandecasteele K, Denys H, De Neve W, Veldeman L. Van Hulle H, et al. Pilot Feasibility Stud. 2020 Oct 10;6:154. doi: 10.1186/s40814-020-00693-z. eCollection 2020. Pilot Feasibility Stud. 2020. PMID: 33062295 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

91 results

Search Page

Filters